Name: 40th Pharmacovigilance UK & EU 2026
Start: 2025-11-11T09:00:00+00:00
End: 2025-11-11T12:00:00+00:00
Location: Sheraton Skyline Hotel London Heathrow

40th Pharmacovigilance UK & EU 2026

11 & 12 March 2026 Sheraton Skyline Heathrow London UK

This event will bring together top pharmaceutical biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers exchange expertise and experiences and arm yourself with the latest information to take your department to the next level. It gives me great pleasure in welcoming all of you to the Virtue Insight’s 40th Pharmacovigilance UK & EU 2026. I wish and pray that all our efforts will be beneficial to our industries and to our all at large.

Please contact Kavitha at E-mail - [email protected] or call +44 20 3509 3779

DELEGATE REGISTRATION:

SUPER EARLY BIRD PRICE (Valid until 11 December 2025)

1 Delegate @ £ 799 + VAT

Group Discount @ £ 1598 + VAT (3 Delegates for the price of 2)

EARLY BIRD PRICE (Valid until 12 Dec 2025 -6 Feb 2026)

1 Delegate @ £ 999 + VAT

Group Discount @ £ 1998 + VAT (3 Delegates for the price of 2)

STANDARD PRICE ( From 7 Feb 2026)

1 Delegate @ £ 1299 + VAT

Group Discount @ £ 2598 + VAT (3 Delegates for the price of 2)

SPONSORS:

We have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. Here you can have a dedicated networking time meet the leading international vendors and expand your knowledge of the latest business models. Please email to [email protected] for more details.

KEY SPEAKERS:

· KARSTEN LOLLIKE Scientific VP Deputy QPPV Global Patient Safety Novo Nordisk

· STEPHANIE MILLICAN Deputy Director BRE II MHRA

· MICHAEL BEAN Senior Director Regulatory Compliance Johnson & Johnson

· FELIX ARELLANO Senior VP and Global Head of Safety & Risk Management Roche

· CHETAN SHATAPATHY Executive Director & Head ADC Group Patient Safety Oncology AstraZeneca

· AZZA ELGHARABLY Associate Director Patient Safety Scientist AstraZeneca

· LEONA HOUGHTON Vice President Global Safety (Ex-US) Mundipharma

· MIRCEA CIUCA Independent PV Consultant / International PV Expert (Former Global Head Medical Safety Organon)

· MIJAL CHAVDA Senior Director Global Head of GxP Inspections & GVP Quality Kyowa Kirin

· REMCO M. DIAB Sr. Dir. Lead Global Safety Officer Immunology & Inflammation Sanofi

· GYORGY ZORENYI Senior Medical Director Medical Safety Jazz Pharma

· VALENTINA MANCINI Senior Director Pharmacovigilance QPPV Shionogi Europe

· CHRISTIAN MUHL Senior Director Compliance GSK

· PAV RISHIRAJ Director Head of Pharmacovigilance Ipsen

· CALVIN JOHNSON Executive Director & Head of International Patient Safety Bristol-Myers Squibb

· LEA GALOVIC Associate Director¸ Risk Management Global Patient Safety & PV Teva

· YVONNE NANCIU Country Head Pharmacovigilance Deputy EU QPPV Bayer

· TEA BABIC Director PV Audits & Inspections Teva

· TERESA SARAGOCA Director Regulatory Affairs & Technical Manager ITALFARMACO

· SABINE POLTERMANN Head of Country Patient Safety Switzerland Bristol-Myers Squibb

· JOHN SOLOMON Former Head of Pharmacovigilance - UK & Ireland Sanofi

· BEGUM BENLI PEKER Head of Patient Safety EU Hub Bristol-Myers Squibb

· SIMON ASHWORTH Head of Pharmacovigilance & Medical Safety MENARINI Group

· SUMIT MUNJAL Global Head of Medical Safety Otsuka Pharmaceuticals

· RISHI CHOPRA Head of International PV & Global PV Operations | Dep. UK QPPV CSL Behring

· PHILLIP EICHORN Global Head of Drug Safety Amryt Pharma

· GALINA CORDERO Head of Pharmacovigilance Dept QPPV JSC Farmak

· WOLF HENNING GEBHARDT R&D Scientist Advanced Analytics Abbott

· ABIDALI FAZAL Safety Science Director Roche

· MARJAN DZEPAROSKI Head of Regulatory Affairs Drug Safety & Intelectual Property Bionika Pharmaceuticals

· RUDI SCHEERLINCK Safety Strategy Lead – Oncology Healthcare Business of Merck

· MICHAEL VON FORSTNER Chief Scientific Officer MedGenie

· RAGHDA MOHAMED Patient Safety Cluster Lead - Middle East & Turkey / Global patient Safety Evaluation Takeda Pharmaceuticals

· GAURI UTTURKAR Benefit Risk Lead (Associate Director) UCB

· LEONARDO PEREIRA Clinical Safety Director Roche

· ARUN RAVINDRAN Benefit Risk Lead (Late phase Clinical Development Safety) UCB

· ZINA SADEQ Director Regional PV & Alliance Management UK QPPV Amicus Therapeutics

· CINTHYA GALICIA QUINTANAR Senior Manager Country Safety Lead Pfizer

· SANJEEV SRIVASTAV Signal Management Lead BioNTech

Plus more joining soon

KEY THEMES DISCUSSED THIS YEAR:

· CHALLENGES / OPPORTUNITIES

· PATIENT SAFETY

· RMP/ REMS

· SAFETY & SIGNAL DETECTION

· AUTOMATION IN PV

· REGULATORY

· MEDICAL DEVICES

· IMPACT OF TECHNOLOGY AI ML

· AUDITS & INSPECTION

· RWE / RWD

· OUTSOURCING

· MARKET TRENDS - CRITIQUES & WAYS FORWARD

WHO SHOULD ATTEND:

CEO’s CTO’s CIO’s Presidents VPs Directors Heads Mgr’s Scientific Advisors Consultants of:

Pharmacovigilance Pharmacoepidemiology Pharmacogenomics Drug/Product Safety Drug Development Information & Clinical Data Management Clinical Pharmacology Clinical Safety PSURs RMP / REMS RWE / RWD Research & Development Quality Assurance Patient Safety Signal Detection Safety Surveillance Outcomes Research Data Analysis Epidemiology Medical Affairs Regulatory Affairs & Compliance Information technology Sales & Marketing

Get more from the event with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.